"Eight years of public lectures, thousands of patients, and one core conviction:
the gap between the operating table and a genuinely recovered life is not a medical failure — it is a system that was never built. Healos™ is that system."
Way Liu
Founder & Director · Healos™ Canada
The story behind Healos™
Way Liu · Founder, Healos™ Canada · Ottawa, Ontario
My father retired in his seventies — not because he had to, but because he chose to. He had spent decades as a senior executive, and he carried himself with the energy of a man twenty years younger. The neighbours used to say he looked fifty. He walked every morning without fail, ate carefully, slept well. By any measure, he was doing everything right.
Then tinnitus crept in — a persistent ringing that threw off his balance. He began stumbling on his walks. A few falls later, his left leg had developed several blood clots. The swelling wouldn't go down. His heart palpitations, already a background worry, became louder. So he went to see a doctor. Then another. Then a specialist. Then more specialists.
Fourteen months passed. Traditional Chinese medicine. Western pharmaceuticals. Different combinations, different dosages, different physicians. The clots were still there. The swelling persisted. There was no sign of improvement.
"My mother had kept this from me for over a year — she didn't want to worry me from so far away. When she finally told me, I was in Canada. I didn't hesitate."
— Way LiuI sent my father the 91-day cellular programme immediately. I called my parents and walked them through every detail — the timing, the quantities, the order of each component, morning and evening. I'd been working with these protocols for years by then. I believed in them. But no one is ever fully prepared for what happens next.
About five weeks later, my mother called. She was happy — genuinely, unexpectedly happy. My father had been lying on the sofa watching television, as he usually did. He looked down at his leg. The swelling was gone. He hadn't noticed it leave — it had simply receded, quietly, while he wasn't watching.
Fourteen months of specialist care hadn't moved it. Five weeks of cellular nutrition did.
My mother had her gallbladder removed ten years before all this. Without it, her metabolism had never quite recovered. Chronic constipation. Persistent headaches and dizziness. Sleep that was shallow and unreliable. She had adapted to all of it, the way people do when something has been wrong for long enough that it starts to feel normal.
The next time I visited my parents in Beijing, I brought enough product for a full year. I stayed for several months. We were careful — tracking her responses, adjusting the protocol, observing. When she went for her blood panel, the physician looked at the results for a long moment.
"In decades of medicine, I have never seen blood this clean in a woman of eighty."
— Her physician, BeijingThose two experiences — my father's leg, my mother's blood panel — became the foundation of everything that followed.
For the first three years of Healos™, almost every client came to us the same way: they had been discharged from hospital, told to rest and take their medication, and had gradually realised that "rest and medication" wasn't returning them to their life. Some had tried cardiac rehabilitation — the standard programme offers around 36 supervised sessions, and fewer than 12% of post-cardiac patients complete it. The results, for those who do finish, are modest at best.
The alternatives are stark. The finest private hospital recovery programmes — the ones that actually work — cost tens of thousands to hundreds of thousands of dollars per year. Long-term care facilities in Canada have waiting lists of five years or more. Good ones are full. And in all of them, the same quiet tragedy plays out: patients arrive, and rarely leave.
Cardiac medications accumulate side effects — CoQ10 depletion from statins, melatonin suppression from beta-blockers, electrolyte loss from diuretics — that no one explains at discharge. Fatigue, brain fog, disrupted sleep, and persistent anxiety aren't signs of weakness. They're measurable cellular deficits. They respond to cellular intervention. But most patients never learn that.
Meanwhile: AI-driven job disruption, rising cost of living, insurance gaps, overloaded physicians with weeks-long appointment waits. The pressure on post-cardiac patients to return to normal life before they've recovered is immense — and the system provides almost no bridge between discharge and genuine recovery.
We started with organic whole-food protocols — sourcing high-quality ingredients, preparing them carefully, often with a family member present to support the patient's routine. It worked. But it was expensive, time-intensive, and impossible to scale. Only families with significant resources and someone willing to dedicate months of their life could access it properly.
That wasn't good enough. Not when cardiac disease doesn't discriminate by income.
Over seven years, we helped thousands of post-cardiac and stroke patients across Canada, the United States, China, Japan, Singapore, and South Korea. We watched cardiologists stare at blood panel results they couldn't explain — multiple markers improving in patients who "shouldn't" be improving this quickly. We heard from patients who had returned to travel, to exercise, to the life they'd been told to accept was behind them.
Those moments of good news — the calls, the messages, the follow-up appointments where everything had shifted — became the reason to keep going through the years when it was genuinely hard to sustain.
But by year seven, I was concerned. No matter how hard we worked, no matter how strong the outcomes, we were barely breaking even. The model that produced the best results required too much — too much time, too much hands-on support, too much cost for the patient. With an MBA background, I knew what had to change: we needed to preserve every bit of the clinical integrity while making this accessible to anyone who needed it, at a fraction of the previous cost.
It took several more years. It required finding the right manufacturing partner — an 18-year-experience US cellular nutrition facility that could produce, certify, and deliver what our protocols required to the standard they demanded, carrying 19 international quality certifications. It required building a systematic approach to what had previously lived in clinical intuition: the H-Index™ — a 32-dimension cellular health audit that captures what blood panels miss, and generates a personalised protocol based on your specific condition, medications, and cellular deficit pattern.
In 2026, that system came online as Healos™ — Heal OS. Heal lots. A complete operating system for cellular recovery.
The goal was never to build a supplement company.
It was to give every cardiac patient access to the kind of recovery that
used to require a six-figure budget and a dedicated caregiver.
In five years, we want to have helped one million post-cardiac and stroke patients
return to a full life — travelling without anxiety, exercising without fear,
living without the daily weight of wondering whether the next event is coming.
That number is our measure of whether we got this right.
Way Liu
Founder, Healos™ Canada · Ottawa, Ontario
Eight years · Six countries · 166+ published articles on cellular cardiac recovery
The outcome data was undeniable. The delivery model needed to change.
Healos™ is the answer: the same cellular logic, delivered through a 24/7 AI-supported,
pharmacist-reviewed, physician-shareable system that any patient can access — without a full-time caregiver.
Soil depletion, industrial food processing, and ubiquitous preservatives and additives have steadily reduced the nutritional density available in even a carefully chosen diet. Patients eating "well" by standard measures are often chronically depleted at the cellular level — a deficit that standard blood panels do not test for and clinical appointments do not address.
Soil micronutrient density has fallen 40–80% in some regions since 1950
Covid-19 infection is now documented to increase near-term cardiac event risk by up to 2.9× (NEJM 2022). Approximately 65 million people globally carry Long Covid — with cardiovascular fatigue, microvasculature inflammation, and mitochondrial dysfunction among the most persistent effects. A generation of patients has entered the cardiac risk pool through a mechanism that did not exist five years ago.
2.9× cardiac risk elevation documented post-Covid (UK Biobank · NEJM 2022)
Ontario LTC wait times now average 5–7 years. 6.5 million Canadians have no registered family physician. Cardiac rehabilitation completion rates sit at 12%. The system was not designed for the volume or the complexity of patients now arriving at it — and the gap between the care patients need and the care the system can provide is widening, not narrowing.
6.5M Canadians without a family doctor · 5–7yr LTC wait · 12% rehab completion
The fundamental model of standard cardiac care is parameter management: lower the LDL, control the blood pressure, manage the INR. These are necessary. They are not sufficient. The oxidative burden, the drug-depleted mitochondria, the chronic micro-inflammation, the psychological fear that doubles cortisol — accumulate untouched between appointments. Cellular restoration requires a different path, not a better version of the same one.
The path to cellular recovery is not through better symptom management. It is parallel to it.
Biotechnology has made cellular-level intervention accessible. High-purity NAD+ precursors, acid-stable SOD, molecular hydrogen, and endogenous mitochondrial cofactors are no longer the exclusive domain of private hospitals or research facilities. Healos™ puts the same cellular tools that were once available only to the privileged few into a structured, trackable, 24/7-supported programme — at a price point that cardiac patients and their families can actually access.
These are not marketing statements. They are the design constraints that shaped
every decision in building the Healos™ system — from the science we cite to the supplements
we chose to the way we structure our relationship with the physicians who care for our patients.
Principle I
"Parameters are the symptom. Cells are the cause."
Your blood pressure reading, your LDL number, your hs-CRP — these are the downstream outputs of what is happening at the cellular level. Standard cardiology manages the outputs. Healos™ addresses the inputs: the oxidative load, the mitochondrial energy deficit, the drug-depleted cofactors, the vascular endothelium that has not yet been given the conditions it needs to repair. Cellular restoration is not an alternative to standard care. It is what standard care cannot yet reach.
Principle II
"We work in the gap your cardiologist cannot reach."
Healos™ will never advise a patient to stop their medications, override their specialist's recommendations, or position itself as an alternative to surgical or pharmaceutical care. The cardiac and vascular system is too important for ideological positioning. Our role is specific: to address the cellular recovery dimensions that fall outside the scope of standard clinical care — not to compete with it. Every patient's physician is kept informed. Every H-Index report is formatted for clinical review. We are allies to the system, not an alternative to it.
Principle III
"Health sovereignty is not a feature. It is a foundation."
Every patient's H-Index data is stored in an isolated Private Firestore Vault — technically separate from every other patient's data, owned by the patient, and shareable only with the clinical team the patient chooses. We do not sell data. We do not aggregate patient profiles for commercial purposes. The physician-ready monthly PDF exists because patients should be able to walk into any appointment with the full picture of their cellular health in their hand — regardless of which system or which institution they are dealing with. Data sovereignty is not a privacy policy. It is a design principle.
Collaborative Growth Nodes — clinical and institutional partners across Canada
In progress
Peer-reviewed publications anchoring the Healos™ protocol in published science
In progress
Patient H-Index baselines — building the cellular health data set that cardiac medicine needs
Tartet: 2027
First Health Canada NPN application — formalising
cellular recovery as a
recognised care category.
Tartet: 2026
Our advisors do not rubber-stamp — they critique. The rigour of their scrutiny is
the source of our confidence in the science we publish and the protocols we deliver.
Dr. Orvill Adams
MD · Former Director-General
World Health Organization (WHO)
Global Health Policy · International Healthcare Systems
Brings global health systems perspective to Healos™ — particularly the structural healthcare gaps that make cellular recovery programmes essential at a population level. Former WHO leadership provides institutional credibility and international policy context.
✓ Signed Advisor
Prof. Basu Sharma
PhD · Professor (Retired)
Faculty of University of New Brunswick
Business Administration · Human Resource · Organizational Studies
Dr. Sharma spent his academic career at the University of New Brunswick's Faculty of Business Administration in Fredericton, retiring in 2024. With nearly 100 publications in business administration, human resources and organizational studies, he brings scholarly rigour to how Healos™ is built and run. At Healos™, he advises on organizational strategy, governance and cross-cultural partnerships.
✓ Signed Advisor
The 4th generation of Traditional Chinese doctor. MA. Professor of UofT. Licensed TCM
Coming soon...
100+
Professional advisor applications currently under review.
Physicians, pharmacists, nutritionists, LTC specialists, and researchers from across Canada and internationally have submitted expressions of interest to join the Healos™ Scientific Advisory Board and Collaborative Growth Node network. Applications are reviewed on a rolling basis. See the For Professionals page for partnership and advisory enquiries.
MANUFACTURING
CLINICAL REFERENCE
MANUFACTURING
CANADIAN FEDERAL LICENSING
INGREDIENT VERIFICATION
INGREDIENT VERIFICATION
INGREDIENT PURITY
INGREDIENT INTEGRITY
THIRD-PARTY TESTING
SPORT & PURITY
EUROPEAN COMPLIANCE
ADDITIONAL CERTIFICATES
Healos™ was not conceived in a boardroom. It was built over eight years of hands-on practice across six countries, thousands of patients, and hundreds of public health lectures — long before the first line of the digital platform was written.
Years of direct integrative practice before digitising the system
Countries where the protocol has been practised and validated: Canada · China · USA · Japan · Singapore · Australia
Public health education lectures delivered — primarily pro bono, hospital and community settings
Articles published on integrative health across Medium, LinkedIn, Facebook, and professional platforms
Industry Award · Integrative Health Innovation
Recognised for contribution to advancing integrative and cellular approaches to cardiovascular health outside traditional clinical settings. Award details available on request.
Industry Award · Community Health Education
Recognised for the reach and impact of the Healos™ public health lecture programme — nearly 100 lectures delivered, primarily to underserved patient populations, at no cost.
Published presence
Professional audience · clinician engagement · case studies
Every element of the Healos™ protocol is anchored to the peer-reviewed literature.
These four papers form the scientific foundation of the 91-day cellular recovery timeline,
the nutrient stack, and the H-Index™ measurement framework.
Cell Metabolism · 2018 · IF: 31.4
Demonstrates that NMN directly restores NAD+ levels — depleted by age, statin therapy, and post-cardiac stress — producing measurable improvement in mitochondrial function and metabolic capacity over 8–12 weeks.
New England Journal of Medicine · 2017 · IF: 176.1
The CANTOS trial establishes that reducing vascular inflammation (hs-CRP) independent of cholesterol management reduces cardiovascular event recurrence by 15% — validating inflammation as a primary target independent of standard lipid therapy.
Cell · 2018 · IF: 64.5
Provides the biological basis for the 91-day protocol timing: endothelial cell renewal occurs on a 60–90 day cycle. SIRT1 activation — enabled by restored NAD+ — reverses the cellular ageing of arterial walls that underlies long-term cardiac risk.
CIHI 2025 · AHA 2024
Documents the structural gap: 12% cardiac rehabilitation completion rates, 6.5M Canadians without a family physician, and the disproportionate economic burden of preventable cardiac recurrence on individuals, families, employers, and the public healthcare system.
When your cardiologist is available for 20 minutes every six weeks, and your LTC institution
is staffed at reduced capacity, and your family doctor's next opening is two months away —
Healos™ is what fills the gap. Every day. Including the ones that matter most.
AI-powered daily touchpoints for accountability, protocol guidance, symptom flagging, and progress tracking. Built on GoHighLevel and n8n — automating 90% of routine patient interaction without removing the human layer for decisions that matter.
24 / 7 · 365
For questions that need a real answer from a real person, VIP and 91-Day Protocol clients have direct WhatsApp access to the Healos™ care team. Responses prioritised within hours. No ticket system. No chatbot queue.
VIP & 91-Day clients
Every month, every patient receives a structured H-Index report formatted for clinical review. Bring it to your cardiologist. Share it with your LTC care team. Show your family physician what is happening at the cellular level between their appointments.
All enrolled patients
Professional enquiries — physician partnerships, LTC institution proposals, advisory board applications, media — are handled personally by Way Liu. Response within 48 hours. No intermediaries for decisions that matter. 365.909.2567 · [email protected]
Professionals · Institutions
The Healos™ protocol was developed and refined across six patient populations in six countries over eight years of hands-on practice. The digital platform serves Canadian patients nationally, with institutional partnerships available internationally.
--- CA Canada (primary · national service) · CN China · US United States · JP Japan · SG Singapore · AU Australia ---
Ottawa, Ontario — Canada's capital and a centre for health policy, cardiac research, and federal regulatory engagement — is a natural home for a programme seeking to change how cardiac recovery is defined at a national level.
ABOUT HEALOS™ CANADA
_________
Healos™ started with one question: why do cardiac patients follow every medical instruction,
yet still feel they are recovering alone in the gap between appointments?
The answer was cellular. The solution became a system — the H-Index™, a 32-dimension
cellular health audit that gives patients, families, and clinicians a shared language for recovery.
Way Liu begins integrative cardiac health practice in Canada. Personal experience with father's vascular condition drives research into cellular recovery.
H-Index™ framework developed. First 32-dimension cellular assessment protocol tested across post-cardiac patient cohort.
Scientific Advisory Board formed. Dr. Orvill Adams (former WHO Director-General) joins as senior advisor.
Healos™ Sovereign Monthly and 91-Day Protocol launched. 19 quality certifications confirmed across manufacturing partners.
noheartattack.com launches. H-Index™ 2.0 in development with expanded drug-nutrient routing and ACHD-specific protocols.

Way Liu
Founder & Director
· Healos™ Canada
"My father's leg clot dissolved in five weeks after 14 months of medication that couldn't move it. The difference was addressing what the medication couldn't reach: the cellular environment. That became Healos™."
Whether you are a patient, a family member managing care, a clinician exploring partnership,
or an institution looking for a better answer — the first step is the same.
Know the cellular picture. The H-Index™ baseline audit is where every Healos™ journey starts.
📞647.472.3880· Way Liu direct ✉️[email protected] 📍 Ottawa · Ontario · Canada
🌐NoHeartAttack.com

A plain account of Healos™: complementary nutrition and follow-up between appointments. What it includes, what it never replaces, how safety works. ...more
The Healos™ Way ,Wellness & Lifestyle Leadership & Assetization Clinical Frontiers Heart Attack & Stent Recovery Stroke Recovery ACHD/Congenital Heart Disease Heart Health Prevention &For Professionals
November 02, 2026•9 min read

Nutrition can't replace statins, blood pressure medicines or your cardiologist. What medicines do that supplements can't, and where Healos™ fits. ...more
The Healos™ Way ,Leadership & Assetization Clinical Frontiers &Heart Attack & Stent Recovery
November 02, 2026•9 min read

Fear after a heart attack or heart surgery isn't just in your head: stress acts on blood pressure, inflammation and the arteries. The biology, and what helps. ...more
The Healos™ Way ,Leadership & Assetization Clinical Frontiers &Heart Attack & Stent Recovery
October 27, 2026•12 min read

Heart and brain recovery share roots but need different nutrition. What the evidence says about omega-3, B vitamins, CoQ10 and Alpha-GPC after stroke. ...more
The Healos™ Way ,Leadership & Assetization Clinical Frontiers Heart Attack & Stent Recovery &Stroke Recovery
September 22, 2026•20 min read

A pharmacist's guide to the five drug-nutrient interactions that come up most in post-cardiac patients, from statins and CoQ10 to warfarin and vitamin K. ...more
The Healos™ Way ,Leadership & Assetization Clinical Frontiers &For Professionals
September 03, 2026•16 min read

Older cardiac patients face a double squeeze: age-related absorption changes and medications that deplete nutrients. What to screen for in long-term care. ...more
Core Health Pillars ,Leadership & Assetization &Clinical Frontiers
September 02, 2026•15 min read
Healos™ Canada — Integrative cellular recovery for post-cardiac, post-stroke, and ACHD patients.
Canada.USA.Mexico.Japan.China.Singapore.Australia...
SMS & voicemail: 365.909.2567
Ottawa, Ontario, Canada
© 2026 Healos™ Canada · NoHeartAttack.com · Ottawa, Ontario Privacy - Terms - Refunds
Healos™ programmes are dietary supplements and integrative wellness services. They are not medical advice, not medical treatment, and not a substitute for professional medical care.
Always consult your physician, cardiologist, or pharmacist before starting any new supplement programme. In case of cardiac emergency, call 911 immediately. Healos™ Canada